Leaflet LATUDA 37mg film-coated tablets
Indicated for: schizophrenia; bipolar disorder
Route of administration: oral
Substance: lurasidone (antipsychotic)
ATC: N05AE05 (Nervous system | Antipsychotics | Indole derivatives)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
This medicine may increase blood sugar.
This medicine may increase the risk of heart rhythm disturbances.
This medicine may increase the risk of seizures.
This medicine may cause drowsiness or reduced alertness.
Lurasidone is an atypical antipsychotic used for the treatment of schizophrenia and depressive episodes associated with bipolar disorder. It works by regulating dopamine and serotonin activity in the brain.
The medication is taken orally, usually once daily, and should be taken with food to improve absorption. It is important to follow the doctor's instructions and not to discontinue treatment abruptly.
Side effects may include drowsiness, nausea, weight gain, or dizziness. In rare cases, severe reactions such as neuroleptic malignant syndrome or tardive dyskinesia may occur.
Lurasidone is not recommended for patients with hypersensitivity to this medication or those taking strong CYP3A4 inhibitors.
General data about LATUDA 37mg
- Substance: lurasidone
- Date of latest medicines list: 01-12-2023
- Product code: W64571002
- Concentration: 37mg
- Pharmaceutical form: film-coated tablets
- Quantity: 28
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for lurasidone
- 18.5mg
- 37mg
- 74mg
